eligibility for clinicaltrials:NCT01292018 [clinicaltrials_resource:0006451ad0ee90dfdcb05df26b77c9a0]
eligibility [clinicaltrials_vocabulary:eligibility]
eligibility for clinicaltrials:NCT01292018 [clinicaltrials_resource:0006451ad0ee90dfdcb05df26b77c9a0]
Bio2RDF identifier
0006451ad0ee90dfdcb05df26b77c9a0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0006451ad0ee90dfdcb05df26b77c9a0
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
gender [clinicaltrials_vocabulary:gender]
healthy volunteers [clinicaltrials_vocabulary:healthy-volunteers]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
minimum age [clinicaltrials_vocabulary:minimum-age]
study population [clinicaltrials_vocabulary:study-population]
Type 2 Diabetics with dyslipidemia on stable dose of Lipid Lowering Drugs(LLDs).
text [clinicaltrials_vocabulary:text]
Inclusion Criteria:
...... ension due to organic diseases
identifier
clinicaltrials_resource:0006451ad0ee90dfdcb05df26b77c9a0
title
eligibility for clinicaltrials:NCT01292018
@en
type
label
eligibility for clinicaltrials ...... 6451ad0ee90dfdcb05df26b77c9a0]
@en